By Aptar Pharma
To get in touch with Aptar Pharma, simply fill out the form below.
Subscribe to Supplier
Inhalation Drug Delivery Solutions to be Displayed by Aptar Pharma at CPhI China
Crystal Lake, Illinois: – Aptar Pharma is pleased to be exhibiting once again at CPhI China 2018, from June 20-22 at the Shanghai New International Exhibition Center, Shanghai, China.
At Booth No. N5F30, we will be introducing new market innovations in inhalation drug delivery for the Chinese market, with our experts on hand to demonstrate the benefits of these exciting respiratory solutions designed to help fight the effects of air pollution.
We will also be showcasing Aptar Pharma’s Bag on Valve (BOV) technology as well as our wide range of advanced preservative-free dispensing systems for dermal, eye care and nasal drug delivery routes, which offer pharmaceutical professionals flexibility and performance when dealing with formulation challenges in the industry today.
An innovation wall at the booth will provide visitors with the opportunity to discover a wide range of Aptar Pharma’s technological innovations, such as PremiumCoat™, the coated stopper that represents a step change in the provision of elastomeric stoppers and offers a reduction in particulates for injectables drug delivery.
Further to exhibiting, we are proud to be hosting a half-day seminar on Friday morning, June 22 from 9.30-11.30am, where two of our Aptar Pharma experts will present the following interactive sessions:
‘Healthy Nose, Healthy Life: A Glance at Global Successful Products for Upper Respiratory Health’ with Guenter Nadler, Director Business Development, Consumer Health Care Division. 9.30-10.30am
‘Say No to Preservatives: Package Innovation for Ophthalmic & Dermal Products’ with Tianjiao Fu, Business Development Manager China, Pharma Sales. 10.30-11.10am
A Q&A session will follow. The seminar will take place at location N8 in Meeting Room D.
To connect with Aptar Pharma and meet our experts, register for CPhI China today: https://registration.n200.com/survey/3o0tmuwtfnigm?cid=pr_VIS_CNV20180110%7C2&actioncode=CPHI1204.